Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Jundishapur Journal of Microbiology
  4. Articles

  5. Construction of a Recombinant OmpC Dominant Epitope-Based Vaccine Against Escherichia coli and Evaluation of Its Immunogenicity and Protective Immunity
  6. Scopus by Title (Ref)

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. In Silico Characterization of Epitopes for Vaccine Design against Escherichia coli based on Heme-Utilization Protein

- Sefid F. , et al.

2. Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review

- Raoufi E. , et al.

3. Immunoprotective evaluation of Escherichia coli outer membrane protein A against the main pathogens of animal mastitis

- Chen C. , et al.

4. Evaluation of immunogenicity, protective immunity on aquaculture pathogenic vibrio and fermentation of vibrio alginolyticus flagellin flac protein

- Chen C. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.